Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Basilea Pharmaceutica AG (BPMUF) Normalized Pre-Tax Income data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Normalized Pre-Tax Income |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$346.45M |
|
$5.88M |
|
$30.66M |
|
$377.10M |
|
$52.53M |
|
$89.39M |
|
$119.15M |
|
$171.68M |
|
$205.42M |
|
$205.14M |
|
$205.42M |
|
12.40M |
|
| Cash Flow Statement Financials | |
$24.01M |
|
$-0.56M |
|
$-6.17M |
|
$205.40M |
|
$222.66M |
|
$17.26M |
|
$3.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|